MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 13.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
3.2 M |
Marktkapitalisierung |
$ 18.6 M |
EBITDA (LTM) |
$ -7.65 M |
P/E (LTM) |
-4.47 |
P/S (LTM) |
28.54 |
EPS (LTM) |
-1.31 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Verastem
VSTM
|
$ 5.04 | -4.73 % | $ 349 M | Nasdaq Global Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 3.96 | -4.12 % | $ 232 M | Nasdaq Global Select Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.57 | -5.87 % | $ 17.6 M | Nasdaq Global Select Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
bluebird bio
BLUE
|
- | - | $ 546 M | Nasdaq Global Select Market,SPB | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 12.41 | -11.1 % | $ 1.88 B | Nasdaq Global Select Market,SPB | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 6.37 | 2.66 % | $ 1.07 B | Nasdaq Global Select Market |  Singapore |
 |
Xenetic Biosciences
XBIO
|
$ 2.72 | -2.86 % | $ 4.63 M | Nasdaq Capital Market | USA |
 |
XBiotech
XBIT
|
$ 2.27 | -1.73 % | $ 69.2 M | Nasdaq Global Select Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 54.48 | -1.89 % | $ 4.24 B | Nasdaq Global Select Market | Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 5.4 | -3.05 % | $ 866 M | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 4.04 | -6.26 % | $ 171 M | Nasdaq Capital Market | USA |
 |
Xencor
XNCR
|
$ 11.42 | -7.23 % | $ 848 M | Nasdaq Global Select Market,SPB | USA |
 |
XOMA Corporation
XOMA
|
$ 30.17 | -1.18 % | $ 364 M | Nasdaq Global Select Market | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
22nd Century Group
XXII
|
$ 2.41 | -18.03 % | $ 444 K | NYSE American | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Cara Therapeutics
CARA
|
- | -3.03 % | $ 260 M | Nasdaq Global Market,SPB | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Zai Lab Limited
ZLAB
|
$ 18.0 | 2.8 % | $ 19.7 B | Nasdaq Global Select Market | China |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.05 | -3.67 % | $ 21.5 M | Nasdaq Capital Market | Israel |
 |
Enochian Biosciences
ENOB
|
- | - | $ 40.5 M | Nasdaq Capital Market | USA |